NEWS

2019

The Nobel Price in Physiology or Medicine 2019 rewards discoveries that form the basis for our drug development projects (2019-10-08)

Labiotech refers to Kancera’s R&D presented at the World Congress of Cardiology/ESC (2019-10-07)

Commissioned analyst report of Kancera AB by Carlsquare (2019-05-29)

2018

Marie Sklodowska-Curie PhD student position at Kancera AB on the role of the fractalkine system in inflammatory conditions (2018-12-20).

Kancera chemistry contributed to one of the new drugs approved in 2017 against cancer (2018-02-01)

2017

Abstract to a presentation on ASH about KAN0439834 (2017-11-09)

The PFKFB3 project is presented at “The 6th EU-US conference on repair of endogenous DNA damage” (2017-09-24)

Kancera’s Fractalkine project appears in BIO Buzz (2017-06-27)

Drug Discovery Today covers Kancera’s Fractalkine project (2017-04-10)

Kancera project update February 2017

2015

Poster at ASH on ROR-inhibitors

Presentation by CEO Thomas Olin in Paris at BIO-Europe Spring 2015